Navigation Links
Pain receptor in brain may be linked to learning and memory
Date:3/13/2008

PROVIDENCE, R.I. [Brown University] Scientists have long known that the nervous system receptor known as TRPV1 can affect sensations of pain in the body. Now a group of Brown University scientists has found that these receptors a darling of drug developers also may play a role in learning and memory in the brain.

In surprising new research, published in the journal Neuron, Julie Kauer and her team show that activation of TPRV1 receptors can trigger long-term depression, a phenomenon that creates lasting changes in the connections between neurons. These changes in the brain and the related process of neural reorganization known as long-term potentiation are believed to be the cellular basis for memory making.

Weve known that TRPV1 receptors are in the brain, but this is some of the first evidence of what they actually do there, Kauer said. And the functional role we uncovered is unexpected. No one has previously linked these pain receptors to a cellular mechanism underlying memory. So we may have found a whole new player in brain plasticity.

The study findings have implications for drug development, Kauer said.

The research points out potentially effective new targets for drugs that could prevent memory loss or could possibly treat neural disorders such as epilepsy, Kauer said. The other implication may be cautionary. Drug makers already sell drugs such as the weight-loss pill rimonabant, which is sold in Europe under the name Acomplia that can block TRPV1 receptors. Other drugs aimed at reducing pain and inflammation by blocking or activating TRPV1 receptors are in the research pipeline. But drugs that bind to TRPV1 receptors in the central nervous system are likely to influence more than just pain-related functions, Kauer said.

Our findings suggest the possibility that some of the psychiatric side effects from rimonabant could be due to the blocking of TRPV1 receptors, she said.

TRPV1, short for tra
'/>"/>

Contact: Wendy Lawton
Wendy_Lawton@brown.edu
401-863-1862
Brown University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cell Receptor on Track for Painless Bladder Cancer Test
2. Scientists determine structure of brain receptor implicated in epilepsy and PMT
3. Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators
4. NIAID scientists identify new cellular receptor for HIV
5. Food peptides activate bitter taste receptors
6. Cell-death receptor links cancer susceptibility and inflammation
7. Receptor protein appears to be key in breakdown of kidney filtration
8. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
9. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
10. Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics
11. Food restriction increases dopamine receptor levels in obese rats
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...taract surgery is higher in patients who have take...rged prostate.// According to the 3 medical assoc...e American Society of Cataract and Refractive Surg...tion, mentioning the use of drugs like Flomax (tam...
...a seriously ill toddler his vital heart monitor du... child who suffers from a rare heart condition has...ous attitude. Stephen Leckey has also appealed to ...ess crime to return the monitor that is an vital p...
...sotretinoin has been found to have more dangerous ... even though it is an effective medication for the...as Accutane in the US and as Roaccutane in UK, and...own to clear up severe acne and prevent scarring, ...
...ng in Australia has found that many South Australi...ving regular screenings// through pap smears. The ...ring 2001-04 more than the 66 in 1997-2000. In th...e was highest with 15 deaths during the period. Pr...
Other Medicine News:Health News:Alpha-blockers call for modification in cataract surgery 2Health News:Alpha-blockers call for modification in cataract surgery 3Health News:Callous Thieves Rob An Seriously Ill Child Of His Vital Heart Machine 2Health News:Acne Drug Found To Cause More Harm than Good 2
(Date:10/7/2008)...al abstracts highlighting CIMZIA,s long-term benef...e patients presented at American College,of Gastro...e-FirstCall/ -- Data from two studies,presented th...terology,(ACG) Annual Meeting demonstrate that CIM...nti-TNF alpha (Tumor Necrosis Factor alpha) - prov...
(Date:10/7/2008)...d 15 Patient Cohort Enrolled in Stage A of Trial A...With Carboplatin and Paclitaxel -, TUSTIN, Calif....aceuticals, Inc. (Nasdaq: PPHM ), a clinical stag...antibodies for the treatment of cancer and,hepatit...t has completed,enrollment in the first stage of a...
(Date:10/6/2008)... and CHIPPENHAM, England, October 7 /PRNewswire-Fi...Mothers Index: 4565) and Vectura,Group plc ("Vectu...tudies,evaluating the efficacy, safety and tolerab...f the European Respiratory Society (ERS) in Berlin...ronium bromide), a novel,inhaled long-acting musca...
(Date:10/6/2008)...N, Oct. 6 /PRNewswire-USNewswire/ -- "A return to ...e development is without scientific,justification,...al,Alternatives to Laboratory Animals (ATLA). "An ...ine Research" concludes that vaccine responses in,...ans, and that claims of,chimpanzees, critical role...
Breaking Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Some Immature Brain Cells May Promote Tumors 9157 1Some Immature Brain Cells May Promote Tumors 9157 2Start Your Day the Sun Shower 28TM 29 Way 9152 1Start Your Day the Sun Shower 28TM 29 Way 9152 2Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference 9147 1Kiwa Fertilizers Pass Independent Tests 2483 1Kiwa Fertilizers Pass Independent Tests 2483 2Kiwa Fertilizers Pass Independent Tests 2483 3
... MALVERN, Pa.--(BUSINESS WIRE)--Apr 18, 2007 - Gem...preclinical data,from a study of its lead compound...tic leukemia (ALL). The study was discussed in an,...rican Association,for Cancer Research (AACR). Acco...ingle agent activity against ALL blast cells,and ...
...lif. and LOS ANGELES, April 18, 2007,/PRNewswire-F...ata,from two preclinical studies, one identifying ...tylase (HDAC) inhibitor and,another demonstrating ...tyrosine kinase (BTK) inhibitor compounds. The dat...ancer Research (AACR),2007 Annual Meeting being he...
Other Medicine Technology:Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 2Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5
... of deflectable curve catheters designed to specif...r patients with small anatomies. Each catheter is ... the finest materials. A unique multi-step process...ion technologies results in the excellent torque a...
... of fixed curve catheters designed to specifically...ents with small anatomies. Each catheter is handcr...inest materials. A unique multi-step process that ...chnologies results in the excellent torque and fle...
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves.
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism.
Medicine Products: